Skip to contentClarengateINTELLIGENCE
Companies/08166456

Absolute Antibody Limited

Private Limited Company · Redcar

ActiveUnited KingdomIncorporated 2012Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2024-12-31

IXBRL · 230 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2024-01-01 to 2024-12-31
Extraction status
Legacy / not assessed
Numeric facts
150
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2025-01-01.xsd
Currency
GBP
Source identifier
Prod224_2601_08166456_20241231
Source archive
Accounts_Monthly_Data-January2026.zip

Accounts to 2021-08-31

IXBRL · 153 source facts · 28 selected values

Not assessed
legacy record
Reporting period
2020-09-01 to 2021-08-31
Extraction status
Legacy / not assessed
Numeric facts
114
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0108_08166456_20210831
Source archive
Accounts_Monthly_Data-July2022.zip

Accounts to 2016-08-31

IXBRL · 89 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2015-09-01 to 2016-08-31
Extraction status
Legacy / not assessed
Numeric facts
64
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0042_08166456_20160831
Source archive
Accounts_Monthly_Data-May2017.zip

Accounts to 2015-08-31

IXBRL · 54 source facts · 20 selected values

Not assessed
legacy record
Reporting period
2014-09-01 to 2015-08-31
Extraction status
Legacy / not assessed
Numeric facts
38
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0027_08166456_20150831
Source archive
Accounts_Monthly_Data-February2016.zip

Accounts to 2014-08-31

IXBRL · 52 source facts · 20 selected values

Not assessed
legacy record
Reporting period
2013-09-01 to 2014-08-31
Extraction status
Legacy / not assessed
Numeric facts
36
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0012_08166456_20140831
Source archive
Accounts_Monthly_Data-November2014.zip

Accounts to 2013-08-31

IXBRL · 37 source facts · 10 selected values

Not assessed
legacy record
Reporting period
2012-08-02 to 2013-08-31
Extraction status
Legacy / not assessed
Numeric facts
21
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_9997_08166456_20130831
Source archive
Accounts_Monthly_Data-December2013.zip

Registered details

08166456
Status
Active
Type
Private Limited Company
Incorporated
2012-08-02
Jurisdiction
Registered office
1WILTON CENTRE, WILTON, REDCAR, CLEVELAND, TS10 4RF, ENGLAND

Classification

1 SIC codes
23112

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

14 matched grants
LipologicLead
Innovate UK · EU-Funded · 2020-10-01 – 2022-09-30
£172,120
awarded
LipologicLead
EU · EU-Funded · 2020-09-30 – 2022-09-29
£172,120
whole project
Lipologic
EU · EU-Funded · 2020-09-30 – 2022-09-29
£172,120
whole project
Cell and Process Engineering for Recombinant Antibody Production
EPSRC · Studentship · 2019-02-04 – 2022-02-03 · with 1 other participant
£0
whole project
University of SheffieldleadAbsolute Antibody Ltd
Point-of-care for stroke subtype diagnosis to enable rapid treatment
Innovate UK · Collaborative R&D · 2018-12-01 – 2021-02-28 · with 5 other participants
£74,677
awarded
Absolute Antibody Limited£74,677
Oxford University Hospitals NHS Foundation Trust£33,407
The Newcastle upon Tyne Hospitals NHS Foundation Trust£32,821
Newcastle University£12,683
Cell and Process Engineering for Transient Expression of Recombinant Proteins in CHO Cells
BBSRC · Studentship · 2018-09-30 – 2022-09-22 · with 1 other participant
£0
whole project
University of SheffieldleadAbsolute Antibody Ltd
mAb manufacturing for future subunit vaccine platform
Innovate UK · Feasibility Studies · 2018-03-01 – 2019-02-28 · with 2 other participants
£27,376
awarded
Absolute Antibody Limited£27,376
mAb manufacturing for future subunit vaccine platform
ISCF · Feasibility Studies · 2018-03-01 – 2019-02-28 · with 2 other participants
£78,011
whole project
Abc2All
EU · EU-Funded · 2017-02-01 – 2021-02-28
£161,505
whole project
Abc2AllLead
EU · EU-Funded · 2017-02-01 – 2021-02-28
£161,505
whole project
Abc2AllLead
Innovate UK · EU-Funded · 2017-02-01 – 2021-02-28
£161,505
awarded
Intramolecular covalent protein cross-links for protein engineering.
BBSRC · Studentship · 2016-09-30 – 2018-10-31 · with 1 other participant
£0
whole project
University Of St AndrewsleadAbsolute Antibody Ltd
Absolute Antibody Ltd - Next generation antibodies for research and diagnosisLead
Innovate UK · GRD Proof of Concept · 2013-05-01 – 2014-04-30
£99,804
awarded
Covalent host targeting by thioester domains of Gram-positive pathogens
MRC · Research Grant · 2012-12-01 – 2015-11-30 · with 5 other participants
£686,719
whole project
University Of St AndrewsleadAbsolute Antibody Ltd.Helmholtz Association of German Research CentresUniversity of LeedsUniversity of St AndrewsUniversity Of York